Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-08

Clinical Trial Update: Colchicine in Acutely Decompensated HFREF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating colchicine for acutely decompensated heart failure with reduced ejection fraction. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: University of Virginia | Conditions: Heart Failure, Decompensated Heart Failure | Phase 4 | Status: RECRUITING